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Abstract
Background: Heart failure (HF) is a progressive disorder which results in poor patient
outcomes for those affected. Although there are evidence-based medications to alter the
progression and improve outcomes, provider adherence to these medications has been
suboptimal. Clinical decision support tools (CDS) within the electronic medical record are
effective tools in medical management.
Objective: The primary objective was to evaluate the use of CDS to nurse practitioners
(NPs) adherence of guideline-directed medical therapy in HF patients in the outpatient
setting. The secondary objective was to assess the NPs perception of facilitators and barriers
that may affect the use of CDS.
Methods: A retrospective chart review was performed to extract HF measures and
preventative care processes documented during an 18-month period by two NPs at two local
primary care clinics in Southeast U.S. Descriptive analysis of the chart data was performed
to compare the results of the Centers for Medicare and Medicaid (CMS) National
performance quality indicators. Additional data was obtained from questionnaires that assess
NPs perceptions and factors that affect the use of CDS.
Results: Collectively, the NPs performance fell below CMS results. However, one NP
exceeded CMS indicators in all areas except blood pressure control. Although the NPs had
some knowledge of CDS, CDS was not used with each patient contact. The satisfaction of
CDS among the NPs was mixed.
Conclusion: CDS use was not verified as a driving factor to the low-performance results as
the use of CDS among the NPs was low. Initiation or adjustment of HF therapy by the NPs
could not be verified within this QIP. Provider education of GDMT and CDS is key to
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improving HF outcomes. Further research using pre- and post-intervention analysis is
warranted.
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Nurse Practitioners Use of Clinical Decision Support Tools in Heart Failure Management
In March 2010, the Affordable Care Act (ACA) mandated that healthcare organizations
replace paper-based records with electronic medical records (EMRs). The ACA provides
incentives to providers who adopt electronic medical records (Kocher, Emanuel, and DeParle
2010). EMRs deliver many benefits to providers including access to patients’ medical history,
current medical treatments, and clinical decision support tools (CDS). CDS are evidence-based
decision aids embedded within the EMR that provide guideline-directed reminders at the point of
contact for timely clinical management of the patient (Vetter et al., 2015). These tools can
support and influence providers in the outpatient setting when providing care to patients with
heart failure (HF) (Gold & McLaughlin, 2016). Due to the chronicity of HF, nurse practitioners
(NPs) are often charged with managing the care of this patient population in outpatient settings.
Although practices for improvement are evolving, NPs are not using these aids to improve
decision making in the management of patients with heart failure (Mitchell, Revere, & Ayadi,
2014; Walsh et al., 2010).
In this quality improvement project (QIP), the student investigator (SI) examines the
background and significance of adequate HF management among NPs in the outpatient setting.
A review of the literature is performed to assess CDS influence on NPs decisions when
managing heart failure patients. Finally, data from two NP-led primary care practices are
analyzed using Donabedian’s Conceptual Framework to evaluate CDS use and the delivery of
guideline-directed medical therapy (GDMT) in heart failure patients.
Background and Significance
Heart failure is a progressive multifactorial disorder that affects over 6 million adults.
The incidence of HF doubles in men and triples in females across a ten-year span. Individuals
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over the age of 65 years of age have the greatest risk of developing HF. African Americans
have a greater incidence of HF than any other nationality (Benjamin et al., 2018; Yancy et al.,
2017). Fifty percent of HF patients will die within five years of diagnosis (Benjamin et al.,
2018). Current research trends show a declining incidence of HF but a rising prevalence of HF
(Komanduri et al., 2017). These changes may be due to an increase of awareness of HF signs
and symptoms and improved diagnostic and treatment (Komanduri et al., 2017). National
hospital admission rates have doubled, and costs of care are expected to rise from $30 billion to
$69 billion by the year 2030 (CDC, 2016; Komanduri et al., 2017). In the state of Georgia,
mortality rates are 5% greater than the national rates. (Georgia Department of Public Health,
2015).
The American College of Cardiology (ACC), the American Heart Association (AHA)
Task Force on Clinical Practice Guidelines and the Heart Failure Society of America (HFSA)
have developed clear guidelines for the care of patients with HF (Yancy et al., 2017). The
guidelines include medications such as angiotensin-converting enzyme inhibitor (ACEi),
angiotensin receptor blocker (ARB), an angiotensin receptor–neprilysin inhibitor (ARNI), and
beta blockers (BB). These medications have all proven to improve symptoms and extend life
(Yancy et al., 2017).
ACEI and ARBS are drugs that affect the renin-angiotensin-aldosterone system (RAAS)
at different pathways within the system. ACEi inhibits kininase and increase levels of
bradykinin and is recommended for mild, moderate, or severe symptoms of HF. A major side
effect of ACEi is angioedema and a cough. ARBs do not inhibit kininase and are less associated
with angioedema and cough (Yancy et al., 2017). ACEi and ARBS have a 17% relative
reduction rate of mortality and a 31% relative reduction rate hospitalization. ARNI is combined

NURSE PRACTITIONER USE

8

with an ARB and a neprilysin inhibitor. Neprilysin breaks down natriuretic peptides, bradykinin,
adrenomedullin, and other vasoactive peptides. ARNI has shown to reduce mortality and
hospitalization by 20% for those with symptomatic HF who are naïve or previously tolerated an
adequate dose of ACEi or ARB. ACEi, ARBs, and ARNI should be used with caution in
patients with low systemic blood pressures, renal insufficiency, or elevated serum potassium
(Yancy et al., 2017). BBs reduce the mortality rate by 35%. BBs are better on improving
ejection fraction, reducing ischemia, and the risk of sudden death. BBs are recommended in all
patients with mild to moderate heart failure. A combination of a BB and ACEi, ARB, or ARNI
is recommended particularly in those with HF with a reduced left ventricular ejection fraction.
Recommendations for these GDMT are to start low and titrate to maximum effect (Yancy et al.,
2017). Although these medications modify the progression and improve the quality of life for an
individual with heart failure, clinicians do not utilize these therapies as recommended (Walsh et
al., 2010).
To improve the delivery of guideline-directed medical therapy (GDMT) and healthcare
outcomes, the EMR may be beneficial (Gold & McLaughlin, 2016). The ACA provided financial
incentives to providers who adopt and implement an EMR within their practice (Kocher et al.,
2010). The goal was to increase access to healthcare information and improve healthcare
outcomes (Kocher et al., 2010). Additional monetary incentives linked to health outcomes are
provided by the Centers for Medicare and Medicaid (CMS) (Bardach et al., 2013). EMRs are
embedded with clinical decision support (CDS) tools that provide clinicians with specific
evidence-based options to assist with the medical management of patients (Mitchell et al., 2014).
CDS adherence improves outcomes (Mitchell et al., 2014; Niemi, Geary, Quinn, Larrabee, &
Brown, 2009). Also, providers can readily address CMS outcome measures with CDS. The
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Community Preventative Services Task Force (2013) recommend the use of CDS embedded with
the EMR for the prevention of cardiovascular disease in the outpatient setting. These
recommendations were based on modest improvements in quality of care outcomes such as
blood pressure control and smoking cessation. As technology advances, CDS use has the
potential for greater improvements in HF patients. Without a deliberate effort to use this
technology, the burden of heart failure will remain unchanged (Hopkins, 2015; Njie et al., 2015).
Problem Statement
NPs provide direct health care services to populations across the lifespan in various
healthcare settings. In the primary care setting, NPs are providing 90% of the services at a
reduced cost and with the same liability costs as a primary care physician (Kraus & DuBois,
2016).

The focus of the NP in this setting is the management and coordination of patients’

preventative and chronic health needs (Scordo et al., 2016). Management of HF patients requires
incorporating and integrating care among many providers (Kuo et al., 2018). With adequate HF
management, patients have decreased exacerbations, hospitalizations, and mortality rate
(Mitchell et al., 2014; Connelly et al., 2012). Also, the evidence shows CDS improves
preventative care processes in cardiovascular patients (Hopkins, 2015). Despite the evidence,
management of HF patients with GDMT is suboptimal (Walsh et al., 2010). As an NP who uses
clinical decision support tools for ordering, prescribing and educating patients in the inpatient
cardiology setting, this QIP will examine the impact of CDS tools in improving the medical
management in HF patients treated in the outpatient setting.
Clinical Question
Does the use of CDS tools impact a nurse practitioner’s adherence to guideline-directed
medical therapy in adult patients with heart failure in the outpatient setting?
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Review and Synthesis of the Literature
Search Strategy
A literature review was performed using the following electronic databases: Cochrane
Library, CINAHL, and PubMed Clinical Queries. Several MeSH terms were used such as
computerized decision support tools, clinical decision-making tools, electronic medical record,
electronic health record, heart failure, adults, heart disease, guideline-directed therapy, provider
adherence, acute heart failure, chronic heart failure, systolic heart failure, and diastolic heart
failure. These MeSH terms were used individually or in combination to find a variety of
published evidence. A total of 38 articles were found related to the use of CDS in various
populations (i.e., diabetes, atrial fibrillation, and hypertension) within the outpatient and inpatient
settings. Articles were selected for review if they met the following inclusion criteria: CDS
tools, adults only, range between 2008 and 2018, published in English, HF, and chronic disease
processes.
Search Results
After careful review, a total of 11 articles were selected: three systematic reviews, three
randomized controlled trials, and five observational studies. In this review, three of the five
studies published in the United States are observational. Outcome targets in nine of eleven of the
studies are related to providers, patients or both and health outcomes in two studies. Health
populations include heart failure and some form of cardiovascular disease (CVD). CDS is
evaluated in nine out of ten the studies reviewed.
Evidence Level and Quality
The quality of the articles was evaluated using the Johns Hopkins Nursing Evidencebased Practice Model (JHNEP). The model has three (I, II, II) levels for research evidence and
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two (IV, V) levels for non-research evidence. The levels of research and type of trials are listed
as follows:
Level I: Random controlled trials (RCT) and systematic reviews (SR) of RCT
Level II: Quasi-experimental studies and systematic review of mixed experimental
studies.
Level III: Non-experimental studies and systematic reviews of experimental and nonexperimental studies (Dang & Dearholt. 2017)
Quality of evidence within this model is assessed at each level and appraised as (a) for
high, (b) for good, and (c) for low based on the consistency of the results, level of control, and
the strength of results and evidence (Dang & Dearholt. 2017). The appraisal for the studies in
this review is three-Ia, two-IIa, one-IIb, four-IIIa, and one-IIIb (Appendix A).
Synthesis of the Evidence
CDS on Outcomes. In this QIP, the associations of CDS on provider and patient
outcomes were neutral in some outcomes and modest in others (Arts, Abu-Hanna, Medlock, &
van Weert, 2017; Peiris et al., 2015; Anchala et al., 2012; Gill et al., 2009; Pearson et al., 2009).
Provider outcomes included measures such as ordering and prescribing patterns. Patient
outcomes included patient lab values and processes for reducing cardiovascular disease (CVD)
risk such as blood pressure control.
Valadri et al., (2017) found acceptable rates of initial doses of BB at 86.4% and low rates
of ACEi/ARBs at 60.3%. The rates of optimal doses for BB and ACEi/ARBs were below
acceptable rates. The researchers noted that optimizing doses for these medications were not
consistently noted in the charts (Valadri et al., 2017). In another study, the use of ACEi, ARBs,
and BBs was lowest among PCPs versus an HF team or a cardiologist in the outpatient setting
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(Crissinger, Marchionda, & Dunlap, 2015). There were modest improvements in the rates of
target doses of ACEi and ARBs with no significant improvements in optimal doses of BBs in a
comparison study of EMR use to paper charting in HF quality indicators (Walsh et al., 2010).
Furthermore, researchers found there were low provider performance rates in four heart failure
measures with CDS implementation versus post-implementation, and rates were lowest in the
southern region of the United States (Mitchell et al., 2014).
In an SR, there were insignificant improvements with preventative care related to blood
pressure management in four studies with CDS use, however the one study with improvements
HF measures noted improvements were at the cost of increased hospital readmissions (Anchala
et al., 2012). The results of an RCT had improvements in screenings for CVD risk factors with
CDS use, but low rates of evidenced-based drugs in individuals at high risk of CVD (Peiris et al.,
2015). A small significant effect of CDS use was noted on quality measures for lipid testing for
patients at high-risk for CVD and in lipid screening (Gill et al., 2009). Findings of increased
financial savings with fewer laboratory, procedures, and prescription orders were noted when
researchers evaluated the EMR effect on HF outcomes in the emergency room (Connelly et al.,
2012).
Impact related to CDS. The impact of CDS on hospitalizations, 30-day readmissions
and mortality were mixed. Among three studies that reported on hospitalizations and mortality,
two showed a positive impact of CDS use and readmissions (Mitchell et al., 2014; Anchala et al.,
2012; Connelly et al., 2012). There was one study with a positive association with CDS and a
reduction of 30-day readmission (Connelly et al., 2012).
CDS Adherence Factors. In most of the studies, provider adherence to CDS and GDMT
was low. The barriers related to provider adherence included lack of time, too many system
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alerts, EMR limitations (Arts et al., 2017). Other barriers included provider awareness,
knowledge, and experience with CDS. Valadri et al. (2017) suggest inconsistent documentation
practices among primary care providers may contribute to the perception of a lack of adherence
to GDMT. Facilitators to use of CDS and GDMT were educational and administrative support
during the implementation of CDS but was only beneficial with provider acceptance (Pearson et
al., 2009; Walsh et al., 2010). Pearson et, al (2009) examined mostly RCTs in a systematic
review that showed GDMT adherence was more successful with educational support (Pearson et,
al 2009). In an RCT, the researchers propose educational support for provider adherence to CDS
and GDMT as post ad hoc improvements were noted in primary and secondary CVD
management (Peiris et al., 2015).
Gap Analysis
Despite the claims that CDS improves healthcare outcomes, the results of the evidence
are inconsistent. The impact of CDS on these outcomes was not statistically significant in most
articles reviewed (Arts, et al., 2017; Bryan & Boren, 2008; Gill, 2009; Pearson et al., 2009;
Peiris et al., 2015; Anchala et al., 2012; Walsh et al., 2010). Only a few studies reported on
heart failure outcomes among NPs and the use of CDS. The articles related to HF (N=5) focused
mostly on physicians and inpatient care and two that examined the effect of CDS. Sample bias,
choice of outcome measures, and diverse EMR technology were provided as issues with designs
of some studies (Arts, at al., 2017; Anchala et al., 2012; Bryan & Boren, 2008).
Project Objectives
The primary objective of this DNP project was to evaluate CDS impact on NPs adherence
of GDMT in HF patients in the primary care setting. Audits of charts were completed for heart
failure patients seen during 01/01/2017-06/30/2018 by evaluating the frequency GDMT and
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preventative care documented within the patient's chart. The charts’ data extracted were
documentation of an ACEi or ARB, ARNI, BB, smoking cessation counseling, and blood
pressure control. Secondary objectives were to assess the nurse practitioners perceptions of
facilitators and barriers in the use of CDS. Any hospitalizations or deaths were included if
documented during the study period.
Conceptual/Theoretical Framework
A conceptual framework is an atlas that shapes and supports a research question and
provides clarity by integrating conceptual processes (Moran et al., 2017). Donabedian’s
conceptual framework is a framework for a quality healthcare inquiry (Berwick & Fox, 2016).
Avedis Donabedian’s framework utilizes a three-tier approach to evaluate quality in healthcare
(Ribeiro-Bittencourt, Ferreira-Santana, Kassladou-Menezes, Cimador & Delvalle, 2016). The
framework consists of tenets created to evaluate management specifically, structure, process, and
outcome (Ribeiro-Bittencourt et al., 2016). These tenets or constructs were used to guide the
DNP research question.
According to Sund, Iwarsson, and Brandt (2015), the structure within the framework
includes permanent or temporary organizational constructs, which may include cost and
regulatory guidelines. Process refers to the standards of care and evidence-based guidelines
within healthcare practices including the ability to identify, diagnose and provide appropriate
care (Ribeiro-Bittencourt et al., 2016). The outcome is the final construct and relates to the
results of the research question as related to competency and clinical behavior (RibeiroBittencourt et al., 2016).
The constructs within the Donabedian’s framework are beneficial to the DNP project as it
examines variables that affect a project’s structure and outcome (Moran et al., 2017). Also, it
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adds value to a project’s variables by showing meaningful relationships within the constructs of
the framework. McKay & Wieck (2014) eludes to the dynamic nature of the framework stating,
“changes in structures and processes of care are required to optimize patient outcomes” (p. 249).
Donabedian’s conceptual framework when applied to the proposed DNP project, will
guide the inquiry to assess outcome quality resulting from the research question. The constructs
as it relates to the project’s variables are as follows:
Structure: Two primary care clinics using EMR integrated with CDS to deliver
GDMT to HF patients
Process: Documentation of ACEi, ARB, ARNI, and a BB or contraindication of these
medications, and documentation of blood pressure control <140/90 and smoking
cessation screening and counseling
Outcome: Chart audit results of process documentation measures and comparison to
CMS 2016 performance results
Donabedian’s conceptual framework will provide structure, definition, and clarity to
investigate, predict, and evaluate the proposed project clinical question.
Methodology
In this QIP, data from a retrospective chart review and questionnaires were evaluated
using descriptive analysis. The quantitative design allowed the SI to quantify the study variables
(Bonnel & Smith, 2014). Descriptive non-experimental methods were used to better understand
the results of the question (Bonnel & Smith, 2014).
Data collection using chart audits offered an inexpensive opportunity to understand past
data. The process was easy and less time consuming than methods in experimental design
(Barick et al., 2018). The providers provided answers to the open-ended questionnaire that
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asked about the nurse practitioner use and perceptions of clinical decision support tools in the
outpatient setting. Follow-up face-to-face visits were performed to obtain additional comments.
Ethical considerations
Approval for the QIP was obtained from Georgia State University Institutional Review
Board (IRB). Informed consent was also granted for the participating NPs. Letters of
cooperation were obtained from two local primary care clinics.
Population/Sample
Sampling Method
Convenience and purposive sampling methods were used for the selection of chart reviews
and primary care NPs. These non-probability sampling methods were chosen versus a
probability method because the population is readily accessible, appropriate for the needs of the
project, and financial costs were negligible (Jager, Putnick, & Bornstein, 2017).
Sampling Criteria
The sample size was derived from the monthly patient volume and nurse practitioner
staffing of each clinic. The monthly patient load was approximately 300 in Clinic A with about
12 active heart failure patients. Clinic B patient load was approximately 400 with about 10
active heart failure patients. A sample size of 30 charts from Clinic A and 40 charts from Clinic
B will be adequate for review. The sample size for the NPs answering the questionnaire was
two, one from each of the participating clinics.
Participants and Inclusion/Exclusion Criteria
The inclusion criteria for chart review included adults 18 years old or greater with a
diagnosis of heart failure with or without symptoms seen between 01/01/2017-06/30/2018.
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Patients with known obstructive pulmonary disease or asthma were excluded as exacerbation are
sometimes difficult to ascertain, and BBs are controversial in this population (Lim et al., 2017).
The inclusion criteria for NP data included board-certification as a nurse practitioner, at
least three years practicing in the outpatient setting and manage heart failure patients. Of the two
participating NPs, one holds a master’s degree in nursing, and the other has a Doctor of Nursing
Practice. Both NPs have board certifications as family practice nurse practitioners and more than
three years practicing as an NP in the outpatient setting, and both NPs manage heart failure
patients.
Setting
The two participating clinics are located in the south Atlanta metropolitan Counties of
Henry and Clayton. According to the 2010 U.S. Census Bureau, Clayton County has a
population of about 259,424 with about 58,797 over the age of 18 and Henry County has a
population of 203,922 with about 59,657 over the age of 18.
Clinic A is located in Forest Park, Georgia and serves the population of Clayton County
and provide care for patients age six months and greater. The clinic has five examination rooms.
The nurse practitioner treats about 15 patients a day and manages patients with heart failure.
Clinic B is located in McDonough, Georgia and serves the people of Henry County and provide
care for patients age six months and greater. The clinic has four exam rooms. The nurse
practitioner treats about 20 patients a day and manages patients with heart failure.
Both clinics have four full-time staff members: an administrator, front office receptionist,
medical assistant, and a nurse practitioner. The clinics use the same cloud-based medical health
records system. The system has clinical decision supports embedded to help with medical
management.

NURSE PRACTITIONER USE

18

Data Collection
Chart review
The student investigator (SI) extracted chart data from the electronic medical record of
both clinics. The SI identified a total of 34 charts based on inclusion criteria: 11 charts from
Clinic A and 23 charts from Clinic B. Two charts were randomly selected from both clinic sites
to verify data initially reviewed for errors to improve reliability.
The SI transcribed chart data onto the data collection sheet. Chart data variables included
demographic information: medical record number, date of birth, gender, and ethnicity.
Additional healthcare data abstracted include International Classification of Diseases (ICD)10
diagnosis codes for heart failure and heart failure symptoms, the number of comorbid conditions
(0-2, 3-4, ≥5), documentation of an angiotensin-converting enzyme inhibitor (ACEi), angiotensin
receptor blocker (ARB), or a beta-blocker (BB), blood pressure, smoking cessation counseling,
hospitalization, and death rates (Appendix B).
Questionnaire
A paper-based questionnaire was created by the student investigator to examine the nurse
practitioner use and perceptions of clinical decision support tools in the outpatient setting. The
questionnaire was adopted and modified using a tool from the Agency for Healthcare Research
and Quality to meet the requirements of the study (2012). The questions included a checklist of
structured answers. Questions 1-5 were related to the design of the EMR and CDS. Questions
6-9 examined the use and perceptions of CDS. Questions 6-8 allowed the provider to explain any
answer chosen. Question 10 included six demographics questions for comparative provider
analysis. Question 11 assessed the provider’s perceived knowledge level of CDS. Provider data
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included age, gender, ethnicity, clinical experience, knowledge, and perceptions of the use of
clinical decision support tools (Appendix C).
Reliability and Validity
Reliability of the questionnaire is unknown to date. A lack of evidence about the use of
the questionnaire among nurse practitioners warrants a reliability analysis in the future. The SI
maintained data validity by designing the collection tools, defining the variables, and collecting
the data for the retrospective chart review and the provider interview. A follow-up review of
data was performed by the SI of two charts from the initial audit for transcription accuracy.
Data Evaluation
The CMS (2018) quality measures were used to compare data extracted from the chart.
The CMS measures include the provision of an ACEi or ARB, BB, and risk reduction with
smoking cessation counseling, and blood pressure control (<140/90).
Data Management and Analysis
An analysis was performed comparing CMS measures to the treatment and management
practices of the participating nurse practitioners to identify areas for improvement. Data were
analyzed using IBM’s Statistical Package for the Social Sciences (SPSS) version 25. Descriptive
statistics were used to quantify data variables (Sebastiao & St. Peter, 2018). Data analysis
included frequency, means, range and standard deviation (SD) to provide clarity to the data.
Means and standard deviations were used for continuous variables such as age and blood
pressure and percentage for categorical variables such as gender and co-morbid conditions (0-2,
3-4, ≥5).
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Results
Chart Audits
Data from 34 charts were extracted for the analysis. There were eleven charts from
Clinic A and 23 from Clinic B. Of the 34 charts; there were 14 with 53 multiple encounters,
seven from each clinic. There were 20 charts with a single encounter, four from clinic A and 16
from clinic B.
Of the total charts reviewed, 44.1 % male and female 55.9 % male. The age of patients
ranged from 35 to 86 years with a mean age of 62.91 (13.11). Most charts reviewed belonged to
patients documented as Black 82.4 % (Table 1).
Table 1
Demographic Characteristics of the Chart Sample (N=34)
Clinic A

Clinic B

Total

Demographic
N

%

N

%

N

%

Age (years)
35-44

1

9.1

1

4.3

2

5.9

45-54

3

27.3

4

17.4

7

20.6

55-64

5

45.5

6

26.1

11

32.4

65-74

0

0

6

26.1

6

17.6

75-84

2

18.2

5

21.7

7

20.6

84-96

0

0

1

4.3

1

2.9

Male

7

63.6

8

34.8

15

44.1

Female

4

36.4

15

65.2

19

55.9

Black

11

100

17

73.9

28

82.4

White

0

0

6

26.1

6

17.6

Gender

Ethnicity
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The clinical characteristics of the sample included heart failure ICD codes, the number of
co-morbidities (0-2, 3-4, ≥5), and symptoms (dyspnea, fatigue, edema, orthopnea, pulmonary
rales, JVD, and hepatomegaly). ICD 10 code I50.9 was the most frequent code documented for
heart failure, unspecified 52.9% (n = 18). The code I50 was the second most code noted and is
unbillable. The chart review showed patients had at least one co-morbidity, 0-2 co-morbidities
(29.4%), 3-4 co-morbidities (61.8 %) and, ≥5 co-morbidities (8.8%). Those that presented with
symptoms were 35.3%. (Table 2).
Table 2
Chart Sample Characteristics
Clinic #1

Clinic #2

Total

Clinical Characteristic
n

%

n

%

n

%

I50

6

54.5

0

0

6

17.6

I50.1

1

9.1

0

0

1

2.9

I50.3

4

36.4

1

4.3

5

14.7

I50.9

0

0

18

78.3

18

52.9

R06.00

0

0

3

13.0

3

8.8

R06.01

0

0

1

4.3

1

2.9

0-2

3

27.3

7

30.4

10

29.4

3-4

7

63.6

14

60.9

21

61.8

≥5

1

9.1

2

8.7

3

8.8

Yes

2

18.2

10

43.5

12

35.5

No

9

81.8

13

56.5

22

64.7

ICD 10 Code

Number of Co-Morbidities

Symptoms
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Charts documented as smokers with smoking cessation counseling was 47.1%, 32.4%
were non-smokers, and 20.6% did have documented evidence. BP control was 41.2% for
<140/90 and 58.8% for >140/90. The mean systolic blood pressure was 149.32 (range 97-230,
SD=29.238) and the mean diastolic blood pressure was 79.85 (range 55-116, SD = 13.87) (Table
14). The results for GDMT was 55.9% (ACEI 32.4%, ARB 17.6%, ARNI 5.9%
contraindications (CIs) 17.6%). Documentation was missing for 26.5% of the charts. There
were 79.4% charts with a documented BB, 17.6 % with CI to therapy and 2.9 % without
documented therapy within the chart (See Table 3).
Table 3
Process Outcomes (N=34)
Clinic #1
Process

n

Clinic #2

%

n

Total

%

n

%

Smoking Cessation Counseling
Smokers

-

-

16

69.6

16

47.1

Non-smokers

4

36.4

7

30.4

11

32.4

Not documented

7

63.6

-

-

7

20.6

4

36.4

10

43.5

14

41.2

13

56.5

20

58.8

Blood Pressure ≤140/90
Yes
No

7

63.6

RAAS Therapy
ACEI

3

27.3

8

34.8

11

32.4

ARB

2

18.2

4

17.4

6

17.6

ARNI

-

-

2

8.7

2

5.9

CI

1

9.1

5

21.7

6

17.6

Not documented

5

45.5

4

17.4

9

26.5

7

63.6

20

87.0

27

79.4

Beta Blocker
BB
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CI

3

27.3

3

13.0

6

17.6

Not documented

1

9.1

-

-

1

2.9

The process data measures were evaluated using CMS quality measures. CMS quality
measures results were reported as an average of individual providers’ performances for each
measure. The providers participating in the CMS incentive program are included during the
2016 reporting period. NPs (N=134,464) were the largest group of providers participating in
incentive programs. However, reporting was low at 14.7% (Table 4). The CMS results
measures for comparison of this project were ACEi/ARB/ARNI/CI therapy 78.1 %, BB/CI
therapy 83.1%, smoking cessation counseling 91.5 %, and blood pressure control 64.7% (Table
5).
Table 4
CMS Quality Reporting Participating Provider Types
Rank

Specialty or Provider
Type

Eligible
N

Participated
N

%

5

Family Practice

115,536

24,511

21.2%

6

Nurse Practitioner

134,404

19,809

14.70%

7

Physician Assistant

93,496

19,280

20.60%

Table 5
PQRS Average Performance Measures
Measure

2015-2016

Average

N

2015

Measure Description
Number

Average 2016

5

ACE/ARB LVSD

2,274

79.2%

78.1%

8

BB LVSD

1,734

82.2%

83.1%

80,717

90.3%

91.5%

Tobacco Screening
226
and Cessation
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Controlling High
236

28,916

63.7%

64.7%

Blood Pressure

The clinical data abstracted included hospitalization and deaths. There were 17.6%
hospitalizations documented 17.4 (n=6) and 2.9% (n=1) documented as deceased for clinical
data (Table 6). This data was included as mortality and hospitalization are the clinical outcomes
that provide evidence of improvements. This information reveals changes in the HF burden.
Hospitalizations and deaths were topics beyond the scope of the QIP but important data to
highlight.
Based on the literature, HF patients discharged from the hospital has higher mortality and 30-day
readmission risks if not managed with GDMT as recommended.
Table 6
Clinical Outcomes (N=34)
Clinic #1

Clinic #2

Total

n

n

n

Clinical
%

%

%

Hospitalization
Yes

2

18.2

4

17.4

6

17.6

No

9

81.8

19

82.6

28

82.4

Yes

-

-

1

4.3

1

2.9

No

11

100.0

22

95.7

33

97.1

Deaths

Donabedian Framework and Measures Comparison
A comparison of CMS measures to the provider's process results was performed using
Donabedian framework. According to the tenet of structure, chart encounters were evaluated
and compared to CMS measures individually and with both clinics combined. The charts audit
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sample (N=34) were broken down based on those with multiple (n=14) and single (n=20)
encounters.
Clinic A had a larger number of multiple encounters while Clinic B had a larger number
of single encounters. The process measures were compared between clinics which revealed
Clinic B performed better in all measures except BP control which were 50% and 37.5%
respectively. The combined total of both clinic outcomes was compared to CMS outcome
measures. The clinics fell below all measures when compared to the CMS measures (Table 7).
Table 7
Comparison of Clinic and CMS Process Measure using Donabedian’s Framework
Single Encounters Outcome
Structure
CDS

Clinic

A

Multiple Encounters Outcome

B
ND

A

B

n=30

n=23

N=20

CMS

ND

Chart

n=4

n=16

N=53

Process Measure
ACEI/ARB/

50

81.3

25

75

56.7

78.3

34

66

78.1

BB/CI

75

81.3

20

80

60.0

100.0

22.6

77.4

83.1

BP Control

50

37.5

-

40

43.3

39.1

-

41.5

64.7

25

100

15

85

40

100

34.6

65.4

91.5

ARNI/CI

<140/90
Smoking Cessation
Note: ND not documented

Provider Questionnaire
Demographics of the providers were one male and one female within the age range of 4554, both self-identified as Black. Both have advanced practice degrees: the male has a Doctor of
Nursing Practice, and the female has a master’s in the science of nursing (Table 8).
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The following questions allowed the SI to examine the use and perceptions of clinical
decision support tools in the outpatient setting (Appendix C).
1. Based on each provider’s experience, the providers agreed that each clinic’s EMR
could allow the user to complete all the tasks provided listed on the questionnaire.
2. Both providers selected yes that CDS was embedded in the EMR at each practice.
3. Both providers responded with a pop-up or drop-down box versus an audible alert.
4. The providers responded that each system allowed a bypass of the CDS presentation
without a required response.
5. The providers selected CDS tasks and ease of use: Clinic’s A provider selected
decisions with lab orders with a rating of 8, and prevention of adverse event, support with
decisions for preventative care, patient education, and patient counseling and rated each a
10. Provider from Clinic B selected and rated all the tasks ten including support with
procedures, medications, referrals, and scheduling follow-up.
6. Provider from Clinic A, selected four facilitators to CDS use: quality in healthcare
commenting “due to CDS reminders”, access to up to date knowledge commenting
“gives information on guidelines and up to date”, patient satisfaction with meeting their
healthcare needs comments CDS “helps you to know what test to provide so patient is
satisfied with care”, and support for comprehensive patient care with comments “if there
are things that are missed, the CDT helps us to know what is missing”. The provider
from Clinic B selected all options listed for facilitators to CDS to use and did not provide
any comments.
7. The provider at Clinic’s A commented that CDS use “does not interfere…use
enhance judgment”. Clinic’s A provider selected the use of CDS prolonged
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documentation of patient care and commented: “yes, but necessary documentation.” The
provider from Clinic’s B did not choose any of the pre-populated barriers writing
“nothing applies.”
8. The provider from Clinic A selected use of CDS was sometimes commenting
“sometimes use the tools if I glance at the notifications for the patient. The provider from
Clinic B selected most times without any explanation.
9. Clinic’s A provider, rated CDS satisfaction as a 2 and Clinic’s B provider satisfaction
of CDS was 8.
10. Providers’ demographics information is noted above for each provider (Table 8).
11. Clinic’s A provider selected knowledge level of CDS was an average user whereas
Clinic’s B provider chose an advanced user.
Table 8
Provider Demographics
Demographics

Provider 1

Provider 2

Gender

Male

Female

Age

45-54

45-54

Race

Black

Black

Hispanic/Latino

No

No

Educational Level

DNP

MSN

Knowledge Level of CDS

Average User

Advanced User

Discussion
Although the results of the quality improvement project suggest that the practitioners are
not in-line with CMS quality measures, the results should be examined with some amount of
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caution as this project did not control for variability in the data. The documentation frequency
for the NPs fell below CMS measures. CMS data showed that ACEi/ARBs therapy was 78.1 %,
BB therapy 83.1%, smoking cessation counseling 91.5 %, and blood pressure control 64.7%.
Among the participating NPs, frequency results were ACEi/ARBs 55.9%, BB therapy 79.4%,
smoking cessation counseling 47.1 %, and blood pressure control 41.2%. The GDMT
documented within the charts was often not started or titrated by the NP. There was missing
documentation for ACEi/ARBS in 26.5% of the charts. These findings are consistent with
previous evidence as provider adherence is low, optimization of therapies difficult to determine,
and incomplete documentation is problematic when evaluating the results. This practice of
incomplete documentation is a concern as ACEi/ARBs have been shown to decrease
hospitalizations which is a strong indicator to increase mortality (Valadri et al., 2017).
The rate of documentation of smoking cessation and high blood pressure among the NPs
in the QIP was 47.1% and 41.2% respectively. As in previous evidence, results of preventative
measures are insignificant and low, particularly in blood pressure management. High blood
pressure is also a major risk factor for cardiovascular disease. Over 480,000 Americans die from
the use of tobacco, and over 78,000 dies from high blood pressure (Benjamin et al., 2018).
According to the American Heart Association, tobacco use increases the risk of cardiovascular
disease and is a leading preventable risk factor of mortality (Benjamin et al., 2018).
The information obtained from the questionnaires suggests that documentation is a
problem among NPs as completion of the questionnaire became a lengthy process.
Documentation was often completed at the end of the day for one provider. One provider uses
templates to cut-down on charting time. Based on the results of the CMS quality report, nurse
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practitioners are in large numbers managing patients with chronic illness, however of the 134
thousand nurses able to transmit quality measures, only 14.7% NPs participated.
Limitations
The retrospective design of the QIP is a limitation. The convenience sampling of the
charts may not be representative of the general population (Vassar & Holzmann, 2013).
However, this method was suitable for the QIP as the NPs practices were small and did not
produce the number of charts expected for review. Additionally, secondary data from chart
review, possible loss of information, and inaccuracy in provider transcription are risks and
threats to validity (Patawala, 2017).
Another limitation was only two NP practices participated in the QIP which increased the
risk of generalizability issues (Vassar & Holzmann, 2013). Nevertheless, the results of this QIP
highlighted problems in providers documentation which provides information for provider
education and further research. The number of charts sampled was smaller than anticipated.
The data from the final chart sample provided the SI with preliminary results for implications for
future inquiry.
Risk of bias was a limitation related to the exclusion of left ventricular ejection function,
and the classification of heart failure as both are important values to consider when initiating
GDMT in HF (Yancy et al., 2017).
Also, unverifiable missing and incomplete data were limitations (Worster, 2004). This
missing data may have skewed the results and difficult to compare to CMS National measures.
The SI selected to keep the charts because deleting the charts would have decreased the sample
and created an increased bias (Worster & Haines, 2004). The SI used missing data as a variable
for post hoc improvement.
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The providers’ answers to the questionnaire were mostly limited to a check mark and
minimal comments which would have given the SI greater information to provide a robust
evaluation. Although both practices have EMRs embedded with CDS, both NPs states that CDS
was not used with each patient contact. The CDS were enabled in both EMRs. However, it was
difficult to access use with HF management retroactively. Documentation of process measures
was also difficult to discern at what point of patient contact occurred. Given this, it is difficult
to establish any impact CDS could have had with NPs management of HF patients.
Summary and Applicability to Practice
The burden of heart failure is well-known in the literature. It affects over 6 million
Americans, the cause of over a million hospitalizations annually, and is associated with increased
mortality. The use of GDMT has shown to improve the quality of life of those affected and
decrease hospitalization and mortality. Nurse practitioners, as first-line providers, must be able
to manage these patients with GDMT effectively.
Advance Practice Nurse Implications. NPs are competent, well-qualified providers to provide
care to individuals with multiple healthcare needs (Bardach et al., 2013). Furthermore, the
primary care provider plays an essential role in outpatient heart failure management. The results
of a large trial by the Veteran Administration (VA) supports NPs in providing quality services by
showing that NP-led clinics in rural areas had a reduction in hospital admissions and mortality in
heart failure patients while decreasing costs and filling the gap in healthcare services (Lowery et
al., 2012). Optimization of GDMT requires frequent close monitoring of vital signs, volume
status, and laboratory findings. Frequent cardiology visits are usually less practical than visits to
the primary care office. NPs in primary care must be empowered to initiate, titrate, and manage
GDMT to improve healthcare outcomes (Valadri et al., 2017).
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Failure to meeting quality indicators and CDS recommendations can have various
implications. Missing or incomplete documentation can lead to penalties from CMS and skew
results of evidence-based studies (Austria, 2015). Non-compliance of quality indicators may
support allegations of negligence. Inaccurate claim codes can result in monetary loss and lead to
charges of fraud (Austria, 2015).
Patient Implications. Patient safety is compromised due to incomplete or poor clinical
practices. Failure to optimize GDMT can worsen HF-related symptoms and outcomes leading to
patient injury, death, and malpractice claims (Austria, 2015). Furthermore, inadequate clinical
practices can lead to decreased patient satisfaction and confidence.
Policy Implications. Current Regulatory and scope of practice policies limit o clinical practices
delivered by NPs. Clinical practice failures may support increased limitations and more stringent
policies for NPs seeking independent practice (Austria, 2015). Likewise, current reimbursement
models reimburse NPs at lower rates than physicians for the same clinical services and claims
codes. The results of inaccurate coding may lead to no reimbursement or fraud and incomplete
documentation to imposed penalties for low performance (Austria, 2015). CMS will assess
penalty fees to providers who care for Medicare and Medicaid patients and do not achieve
quality measures goals (CMS, 2018).
Conclusion
The evidence provides data about provider differences, educational support and clinical
management incentives that affect adherence to CDS, GDMT and HF outcomes. NPs must
increase their knowledge of CDS by utilizing educational and technical support to become more
confident in managing complex patients and compliance of GDMT (Walsh et al. 2010).
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CDS are support tools to influence the providers to deliver evidence-based therapies.
However, a critical gap between guidelines and practice is provider adherence. More evidence is
needed targeting NPs as most articles reviewed in this QIP targeted physicians or physician
practices. Stronger evidence supporting NPs use of CDS when managing HF in the outpatient
setting is vital to help decrease morbidity and mortality in this population because the HF burden
is forecast to increase (Komanduri et al., 2017).
The NPs in this QIP would benefit in further education on CDS, GDMT, CMS quality
measures for improved management and documentation of HF patients. Innovative designs for
educational and technical support are important for provider engagement and acceptance of CDS
when treating heart failure patient (Walsh et al. 2010). CDS are valuable tools for providers that
can have a positive influence on disease management health outcomes in the outpatient setting
(Arts, at al., 2017; Peiris et al., 2015; Anchala et al., 2012; Walsh et al., 2010; Gill, 2009).
Dissemination
The plan for dissemination of this QIP includes a formal presentation to defend to the
DNP staff, colleagues, and team members. Also, the SI will deliver a formal presentation to the
two clinics that participated in the project. An abstract was accepted to be included the Annual
Lewis College Graduate Research Conference. Finally, a post hoc case study to educate NPs in
the community regarding using CDS in heart failure management and outcome improvements
and submit a case study for publication.
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Appendix A: Review of Literature Matrix
Review of Literature Matrix
Author
Arts et al.,
2017

Design
RCT

Country
Netherlands

Valadri et al.,
2017

OBS

U.S.

Crissinger et
al, 2015

OBS

U.S.

Peiris, et al.,
2015

RCT

Australia

Mitchell, et al.,
2014

OBS

Connelly, et
al., 2012

OBS

U.S.

US

Sample
Measurement
N=731
Provider
PCP clinic adherence with
CDS; document
reason for nonadherence
N=155
Provider
adherence
GDMT in HF
N-641
Differences in
307 HF,
GDMT therapy
258 CV,
among provider
and 76
types: PCP, CV,
PCP.
HF team
N=60
CDS QI effect
outpatient on CVD risk
clinics: 30 management and
communit prescription rates
y/ 30 GP
N=2335
CDS effect on
hospitals
30-day
admission and
CMS process HF
measures

Results
Low use of CDS; noted reason,
non-capture
-Barriers: lack of time, too may
alerts, limitation in system
function
Low Optimization of GDMT
-PCP reluctant d/t possible
cardio-renal imbalances
HF teams adhered most often
target and optimal therapies
-PCP low adherence

Target
Provider
Afib

Strength
Ia

Provider
HF

IIIa

Patient
HF

IIIb

Positive effect on CVD
preventative management; no
effect on prescription rates

Provider
CVD

N=5166
3 ED

EMR effect on
hospitalization,
LOS, inpatient
mortality

2/3 lower mortality, 1/3 lower
hospitalization, 1/3 prolonged
ED stay; however, decrease
procedure/labs orders

Clinical
Provider
HF

Variable results on prevention:
no effect on HF; increased on
TIA/CVA w/o impact; HF
improved processes at cost of
increased readmission rates;
30% reduction AMI; however,
no differences between groups
on mortality or readmission
CDS with moderate effect
measures: ACEi/ARB/BB

Patient
CVD

IIb

Provider
HF

IIIa

Positive correlation with CDS on Clinical
30-day readmission rates; no
Provider
correlation with CMS HF
HF
measures

Ia

IIIa

IIIa

Raghupathy et
al., 2012

SR-MA

Multiple

N=10

CDS effect on
prevention of
CVD, HF,
TIA/CVA and
CAD

Walsh et al.,
2010

OBS

U. S

EHR vs paper:
on CMS quality
measures

Pearson et al.,
2009

SR

Multiple

N=167
Outpt
Target:
HF PT
N=56
50-RCT
6-Quasiexp

Impact CDS on
prescribing
practices in inpt
vs outpt setting

16 related to CVD- 4 showed
positive impact on majority of
outcomes

Provider
CVD

IIa

Gill et al.,
2009

RCT

U.S.

N=25
12 I
13 C

CDS effect on
lipid testing,
goals and # of
prescription

Lipid testing increased
LDL-C goal increased
Increased # of prescriptions.
No differences among groups

Provider
CVD

Ia

Bryan &
Boren, 2008

SR

US

N=17:
12RCT
5-NRCT

CDS effect
healthcare
outcomes

13-positive or variable outcome;
4- no significant outcome

Provider
Patient
CVD
Depression

IIa
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Appendix B: Chart Audit Tools
Table B1: Abstraction Tool
Data Abstraction Tool
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Table B2: Abstraction Tool Code Sheet
CODES
J80
R06.00
R06.01
R06.02
R06.09
R06.89
R06.9
G93.3
R53.0
R53.1
R53.81
R53.83
R60.0
R60.1
R60.9
I50
I50.9
I50.1
I50.20
I50.21
I50.22
I50.23
I50.30
I50.31
I50.32
I50.33
I50.40
I50.41
I50.42
I50.43
I50.1

DESCRIPTION
DYSPNEA
Acute respiratory distress syndrome
Dyspnea, unspecified
Orthopnea
Shortness of breath
Other forms of dyspnea
Other abnormalities of breathing
Unspecified abnormalities of breathing
FATIGUE
Post viral fatigue syndrome
Neoplastic (malignant) related fatigue
Weakness
Other malaise
Other fatigue
EDEMA
Localized edema
Generalized edema
Edema, unspecified
HEART FAILURE
Heart failure
Heart failure, unspecified; Biventricular (heart) failure NOS; Cardiac, heart or
myocardial failure NOS; Congestive heart disease; Congestive heart failure; Right
ventricular failure (secondary to left heart failure)
Left ventricular failure; Cardiac asthma; Edema of lung with heart disease NOS;
Edema of lung with heart failure; Left heart failure; Pulmonary edema with heart
disease NOS
Unspecified systolic (congestive) heart failure
Acute systolic (congestive) heart failure
Chronic systolic (congestive) heart failure
Acute on chronic systolic (congestive) heart failure
Unspecified diastolic (congestive) heart failure
Acute diastolic (congestive) heart failure
Chronic diastolic (congestive) heart failure
Acute on chronic diastolic (congestive) heart failure
Unspecified combined systolic congestive) and diastolic (congestive) heart failure
Acute combined systolic (congestive) and diastolic (congestive) heart failure
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
Acute on chronic combined systolic (congestive) and diastolic(congestive) heart
failure
Left ventricular failure; Heart failure, unspecified; Biventricular (heart) failure NOS
Cardiac, heart or myocardial failure NOS; Congestive heart disease; Congestive
heart failure; Right ventricular failure (secondary to left heart failure
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Appendix C: Provider Questionnaire
Clinical Decision Support Tools Survey
Instructions
When completing the questionnaire, you may leave blank any questions that you do not want to answer. We will
keep your responses strictly confidential. This questionnaire has been designed to gather information about your
perceptions on the use of clinical decision support tools among nurse practitioners in the outpatient setting.
Based on your experience, which tasks are you able to complete within the medical record?

Choose all that apply
Obtain and review patient information and data
Document care for my patients
View lab tests for my patients
Prevent adverse events (e.g., drug-drug interaction, drug-allergy interaction)
Track preventive care for my patients
Manage chronic disease conditions for my patients
Manage orders
Manage referrals
Provide patient educational materials
Does your electronic medical record include clinical decision support tools?
□

Yes

□

No

If so, in what format does the clinical decision support tools presented within the electronic medical record?
□

Pop-up or drop-down box

□

Audible alert

Based on the format of the software for the clinical decision support tool, is there a requirement to respond or are you
allowed to bypass the presentation?
□

Required response

□

Bypass

Based on your knowledge of clinical decision support tools, which tasks do you use clinical support tools when
managing patients? Rate the ease of completing each task on 0-10 scale

Choose all that apply
Decisions with lab orders
Decisions procedure orders

√
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Decisions with medication order
Prevent adverse events (e.g., drug-drug interaction, drug-allergy interaction)
Decisions with preventive care for my patients
Decisions with referral
Decisions with patient education, such medication
Decisions with patient counseling
Decisions with follow-up timing

Based on your experience, identify and discuss factors that facilitate the use of clinical decision support tools within
your practice?

Choose all that apply

√

Explain

Costs of providing care
Quality of health care
Stress-level
Provider and patient
communication
Access to up- to-date knowledge
Patients' satisfaction with meeting
their healthcare needs
Your ability to manage more
complex problems
Providing comprehensive of
patient care
Efficiency of clinical practice
Avoiding errors (such overlooking
a drug)

Based on your experience, identify and discuss any barriers that prevent the use of clinical decision support tools?

Choose all that apply
Use interferes with patient
interaction.
Use has increased my workload.

√

Explain
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Use does not enhance my
judgment when managing a
patient.
Use prolongs documentation of
patient care.
Other

Based on your experience, please indicate how often you use clinical decision support tools in
your practice as a nurse practitioner? Explain

√

Every time
Most times
Sometimes
Not at all
N/A

Rate your satisfaction with clinical decision support tools on a scale from 0-10

Tell me about yourself

Gender

Male

Female

Age

34 or less

35-44

Hispanic/Latino

Yes

No

Race

American

Asian

Indian

45-54

55+

Native

Black

Hawaiian or

African

(specify)

Pacific

American

________

White

Other:

Islander
Highest

High School or

2-year

4-year

Master’s

Doctoral

Profession

Education Level

GED

college

college

degree

degree

al degree

degree

degree (BA,

(MA, MS)

(Ph.D.,

(MD,

(Associate)

BS, BSN,

DNP,

PharmD)

etc.)

etc.)

Choose the best description of your knowledge of clinical decision support tools
Novice (newly acquired knowledge)

√
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Average user (knowledge of clinical decision support tools to manage patient and complete
documentation)
Advanced user (Knowledge to adjust clinical decision support tools based on your
preferences)
Expert user (Knowledge to set up and develop clinical decision support tools within the
electronic medical record)
Thank you for completing this questionnaire. This information will help us better understand the use and perceptions
of clinical decision support tools among nurse practitioner in the outpatient setting.
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Appendix D: Timeline
Timeline
Task

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2018
Proposal
Approval
Proposal
Presentation

x

Consent to
Providers

x

Interview with
providers

x

Chart review

x

Pre-Defense Paper

Apr

x

IRB approval

Results to team

Mar

x

x

Analysis of
outcomes

Feb

2019

IRB apply

Evaluation

Jan

x
x
x

x
x

x
x

Dissemination
Plan

x

Final paper to
Team

x

Abstract
Submission

x

Defense

x

DNP Project
Manuscript

x

DNP Final Post
Defense

x

Complete IRB
Closeout

x

